569667-93-2Relevant articles and documents
AZETIDINE AND SPIROAZETIDINE COMPOUNDS AND USES THEREOF
-
Page/Page column 47, (2021/12/30)
The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
Aromatic cycloamines derivative and application in multi-target antidepressant medicine
-
Paragraph 0079; 0080; 0088; 0089; 0096-0098, (2019/11/29)
The invention discloses an aromatic cycloamines derivative and an application in multi-target antidepressant medicine. The aromatic cycloamines derivative has inhibitory activity on 5-HT reuptake, NEreuptake and DA reuptake, is a novel compound of a 5-HT/
Novel Compounds
-
Page/Page column 75; 76; 77; 78, (2017/07/06)
The present invention relates to novel compounds and methods for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention relates to the inhibition of ubiquitin C- terminal hydrolase 30 or Ubiquitin Specific Peptidase 30 (USP30). The invention further relates to the use of DUB inhibitors in the treatment of conditions involving mitochondrial dysfunction and cancer. Compounds of the invention include compounds having the formula (I): (I) or a pharmaceutically acceptable salt thereof, wherein R1a, R1b, R1c, R1d, R1e, R1f, R1g, R2, X, L and A are as defined herein.